Comparing the efficacy of regorafenib and 5-fluorouracil-based rechallenge chemotherapy in the third-line treatment of metastatic colorectal cancer (vol 24, 16, 2024)
Loading...
Date
Journal Title
Journal ISSN
Volume Title
Publisher
BMC
Access Rights
Attribution 4.0 International
info:eu-repo/semantics/openAccess
info:eu-repo/semantics/openAccess
DOI
10.1186/s12885-024-11863-0
Abstract
Description
Keywords
Journal or Series
BMC Cancer
WoS Q Value
Scopus Q Value
Volume
24
Issue
1
Citation
Şenocak Taşçı, E., Oyan, B., Sönmez, Ö., Mutlu, A. U., Atçı, M. M., Sakin, A. ... Bozkurt, M. (2024). Comparing the efficacy of regorafenib and 5-fluorouracil-based rechallenge chemotherapy in the third-line treatment of metastatic colorectal cancer (vol 24, 16, 2024). BMC Cancer, 24(1). https://dx.doi.org/10.1186/s12885-024-11863-0
Endorsement
Review
Supplemented By
Referenced By
Creative Commons license
Except where otherwise noted, this item's license is described as Attribution 4.0 International
